Member Info for Adastra

Just waiting on the OK 3 Belluscura shares for every 4 TMTA shares to be approved as a cost-effective risk-managed way of getting exposure to Bells oxygen concentrator roll out. The RNS regarding Chinese certification for use could transform Belluscura as it targets far east.

Exploit the difference! Just done it myself....

£2000 will currently buy, with costs,

12456 TMTA or 9068 BELL

With TMTA you are induring your risk with assets worth 17.25p a share versus 15.9p to buy.

The merger/takeover of BELL and TMTA is on a 3 BELL for every 4 TMTA

12456 divided by 4 is 3114

Multiplied by 3 is 9342 BELL.

So cheaper to buy TMTA and its got 17.25p per share assets underpinning it.

Exploit the difference!

£2000 will currently buy, with costs,

12456 TMTA or 9068 BELL

With TMTA you are induring your risk with assets worth 17.25p a share versus 15.9p to buy.

The merger/takeover of BELL and TMTA is on a 3 BELL for every 4 TMTA

12456 divided by 4 is 3114

Multiplied by 3 is 9342 BELL.

So cheaper to buy TMTA and its got 17.25p per share assets underpinning it.

Https://www.investegate.co.uk/announcement/rns/belluscura--bell/chinese-registration-and-trading-update/7952687

TMT acquisitions announce in RNS this morning that it's takeover/merger with Belluscura is imminent giving BELL immediate access to almost £5m cash to exploit big increase in demand. Quote:

The Offer adds a significant injection of working capital into Belluscura, enabling it to capitalise on its burgeoning opportunity in a fast-growing global market. The Offer also enhances Belluscura's ability to leverage its position as a provider of innovative oxygen enrichment technology. Given the introduction and significant pre-launch demand expressed for Belluscura's DISCOV-R product, building on top of the continued sales progress of the X-PLOR, the directors of Belluscura and the directors of TMT Acquisition believe the Offer has compelling strategic logic which significantly increases Belluscura's ability to execute on its burgeoning sales pipeline and strategy, whilst creating considerable potential value for all shareholders of both TMT Acquisition and Belluscura. The Company is pleased to confirm it is in receipt of irrevocable undertakings and a letter of intent to accept the Offer from TMT Acquisition Shareholders holding, in aggregate, 16,805,418 TMT Acquisition Shares (representing approximately 61.11% of the issued share capital of TMTA). As announced on 28 November, it is anticipated that it will shortly post the Offer Document to TMT Acquisition Shareholders.

Onward and upward....2024 should be transformational.

Just taken a quick 15% profit on Sondrel and put it into Belluscura. I see this doing a very strong reversal in the next 7days as TMT news arrives bolstered but updates.

True but I've taken the quick 15% profit on half my holding and put into BELL as I see decent upswing becoming there.

Some here, some there......happy.

Https://www.ensilica.com/news/ensilica-enters-strategic-partners-with-design-and-custom-module-developer-indesmatech/

Plenty of ASIC users across multiple industries..Sondrel and Ensilica will both benefit from confidence in UK signals like this.

UK's Pragmatic secures £182M for expansion of silicon-free chip production

Marking the largest-ever European semiconductor venture funding round, Pragmatic intends to add at least six more manufacturing lines in the UK over the next five years.

Music to the ears of the UK microelectronics industry..

UK's Pragmatic secures £182M for expansion of silicon-free chip production

Marking the largest-ever European semiconductor venture funding round, Pragmatic intends to add at least six more manufacturing lines in the UK over the next five years.

The secret is to spot the prospects and projects underway. It's virtually impossible to buy at the bottom and sell at the top but spotting the reversal just before it happens usually works in an undervalued under researched share. This is an experienced team in a high growth field with blue chip clients. Anything under 70p imo is good value this month.

Please can someone explain why this tech is environmentally friendly given that the ammonia is synthetically produced using the energy consuming Haber-Bosch process by OCI?

OCI Global Ammonia Production

ChatGPT 3.5

User

How does OCI global produce ammonia?

ChatGPT

OCI (OCI N.V.) is a global company involved in various industries, including chemicals. Ammonia production typically involves the Haber-Bosch process, which synthesizes ammonia (NH3) from nitrogen (N2) and hydrogen (H2) gases.

In the Haber-Bosch process:

Nitrogen is extracted from the air.

Hydrogen is obtained from natural gas or other hydrocarbon sources through a process called steam methane reforming.

The nitrogen and hydrogen gases are then reacted under high temperature and pressure in the presence of a catalyst to form ammonia.

OCI Global likely utilizes variations of this well-established industrial process to produce ammonia for various applications, such as fertilizers and other chemical products. The specific details of OCI Global's operations would depend on their chosen technologies and facilities, which may evolve over time.

Both Ensilica and Sondrel are in sweet spots for transformational upgrades in 2024 as their tape outs and projects bear fruit. The value of contracts in this space is huge and both companies have the resources and capabilities match and beat global competition. Two British high tech gems being totally overlooked at the moment, sitting at near all-time lows. Once these start to attract attention I'm sure the tide will turn and investor sentiment will follow.

Bought in on the drop at just under 7p on Friday. Happy to hold today as it's held up nicely and we should get holding notice tomorrow. This has value embedded at this level and a good chance of decent upside imo.

Last upbeat RNS plus bottoming out...I'm in.

Should get an RNS on the pickup of all Siemens shares tomorrow.....quite interested to see if all the 10k+ block lots today were being picked up by one or two industry players.

Impetus has been building in the totally recyclable drinks packaging ReZorce. Zotefoams is working with a "global packaging supplier" aiming for commercial roll out in Q1 2024. The fact that ReZorce is immediately transferable to existing end-user packaging equipment is pivotal as the changeover is seamless and requires no Capex. That immediately ups the green credentials of the customer so it looks like a win:win across the interface from start to finish. This should certainly light-up the 2024 share recommendations by numerous Christmas tipsters. Could Be a real blockbuster next year based on well-advanced trials and scale-up.

This has to be a buy on forward contract projections, milestones achieved. Tapeouts in progress are sticky and roll outs lucrative. The fact that Sondrel is one of only three global companies working at 3nm specs driving micro AI is pivotal to a swift reversal here.

Immediate earnings benefit of consolidation and very valuable ASIC contracts all brought under one roof... methinks who's running the upside at ENSI?